Metformin increases antitumor activity of MEK inhibitor binimetinib in 2D and 3D models of human metastatic melanoma cells.
Biomed Pharmacother
; 109: 2548-2560, 2019 Jan.
Article
in En
| MEDLINE
| ID: mdl-30551515
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Benzimidazoles
/
MAP Kinase Kinase 1
/
MAP Kinase Kinase 2
/
Melanoma
/
Metformin
Limits:
Humans
Language:
En
Journal:
Biomed Pharmacother
Year:
2019
Document type:
Article
Country of publication: